通过使用计算方法,研究阿育吠陀草药配方Rasayana Churna的衰老调节机制
Amisha Bisht1, Anita Nayal2, Disha Tewari3
1Department of Botany, Pt. Badridutt Pandey Campus Bageshwar, Soban Singh Jeena University, Almora, Uttarakhand, 263601, India.
拉萨亚那·丘尔纳 (Rasayana Churna) 是一种阿育吠陀配方,通过其生物活性化合物向关键衰老路径,如AKT1.1,显示其在治疗衰老疾病方面的潜力. 计算分析支持其使用,但临床验证仍在等待.
科学领域:
- 艾尔韦达医学是一种医药.
- 计算药理学是一种计算药理学.
- 衰老的研究研究.
背景情况:
- 老龄化与各种疾病有关.
- 像Rasayana Churna这样的阿育吠陀配方传统上用于与年龄相关的疾病.
- 了解分子机制对于验证至关重要.
研究的目的:
- 调查Rasayana Churna在治疗与衰老有关的疾病中的影响和机制.
- 为了识别Rasayana Churna的生物活性化合物和分子标.
- 为了通过计算验证Rasayana Churna的抗衰老潜力.
主要方法:
- 在Rasayana Churna的属性中进行文字挖掘.
- 网络药理学用于识别化合物和标.
- 分子对接,分子动力学 (MD) 模拟,超级MMPBSA和密度函数理论 (DFT) 分析.
- 基因本体学 (GO) 和KEGG通路丰富分析.
主要成果:
- 文字挖掘揭示了关键成分的抗糖尿病,抗氧化和抗炎性质.
- 网络药理学确定了17种生物活性化合物和137个标,其中AKT1,BCL2,ESR1和GSK3B是关键的与衰老相关的标.
- 分子对接和MD模拟确定了Kaempferol,N-Caffeoyltyramine和Multifidol glucoside作为对AKT1的强有力的结合剂,显示出卓越的稳定性和结合亲和力.
- DFT分析证实了这些化合物的有利电子特性和动力稳定性.
结论:
- 拉萨亚纳丘尔纳拥有其生物活性化合物介导的潜在抗衰老特性.
- 计算方法为了解其抗衰老机制提供了坚实的基础.
- 建议进行进一步的体外,体内和临床研究,以验证其有效性.
更多相关视频
14:57Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
Published on: March 23, 2011
07:58Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
相关概念视频
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
The Ras Gene
Ras is a...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
